Dr Vishal Gulati is a venture capital investor focusing on the convergence of data, healthcare and biology.
Over the last two decades, Vishal has focused on helping innovators transform great scientific discoveries into successful businesses in digital health, AI and computational biology, most recently as a partner at Draper Esprit plc, a leading European venture capital firm.
In addition to Vishal’s role at Draper Esprit, he is an independent director on the board of two publicly listed companies, Horizon Discovery (Cambridge) and Sensyne Health (Oxford) and is chairman of Digital Health Forum and serves on Innovate UK’s Major Award Committee. Vishal also mentors first time founders who are leaving academic careers to start technology businesses. He has helped commercialise clinical products in the mental health, women’s health and primary care sectors, improving the lives of millions of people worldwide.
Prior to this, Vishal worked at Atlas Venture, The Wellcome Trust and Radiant Capital. Vishal received his postgraduate medical training at centres including the Nuffield Department of Medicine (Oxford) and Department of Medicine (St Mary’s Hospital, London) as a Rhodes Scholar.
Dr Vishal Gulati trained as a physician in India and did his postgraduate research in clinical medicine at the University of Oxford and Imperial College as a UNESCO MCBN Fellow and a Rhodes Scholar. Vishal is also a Senior Advisor at Oxford Science Innovation (OSI), and serves on the awards panels of the British Heart Foundation, Innovate UK, MRC, and Cancer Research UK.
